CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN
- 1 February 1986
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 327 (8475), 256-258
- https://doi.org/10.1016/s0140-6736(86)90786-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A new method for studying cell growth in suspension, and its use to show that indomethacin enhances cell killing by methotrexateJournal of Pharmacy and Pharmacology, 1985
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- RENAL COMPLICATIONS OF CYTOTOXIC THERAPYAustralian and New Zealand Journal of Medicine, 1983
- Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatmentCancer Chemotherapy and Pharmacology, 1983
- An enzyme immunoassay design using labelled antibodies for the determination of haptens. Application to methotrexate assayJournal of Immunological Methods, 1983
- Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory DrugsClinical Pharmacokinetics, 1983
- Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storageJournal of Pharmacological Methods, 1981
- Reporting results of cancer treatmentCancer, 1981
- Prolongation and enhancement of serum methotrexate concentrations by probenecid.BMJ, 1978
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978